FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37649611000001100: Talzenna 0.25mg capsules (Pfizer Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
418991000001117 Talzenna 0.25mg capsules (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
419001000001117 Talzenna 0.25mg capsules (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Talzenna 0.25mg capsules (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Is a Talazoparib 250microgram capsules true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Is a Talzenna true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Talazoparib false Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has specific active ingredient Talazoparib tosylate false Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has specific active ingredient Talazoparib tosylate true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Talzenna 0.25mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Talazoparib false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Talzenna 0.25mg capsules (Pfizer Ltd) 30 capsule Has AMP True Talzenna 0.25mg capsules (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start